Analysis of the impact of AHRQ exclusions on the variation in Patient Safety Indicator (PSI) values

Similar documents
Proposed Expansion of the Patient Safety Indicator Set Patrick S. Romano, MD MPH UC Davis/USA

PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK

Methodological Issues

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

A Pause in the Availability of Risk Adjusted National Benchmarks for AHRQ Indicators and an Alternative Measurement Approach

Indicators of suicide among people with serious mental illness

Appendix G Explanation/Clarification Summary

Appendix 1. Validation studies of Agency for Healthcare Research and Quality (AHRQ) patient safety indicator (PSI) Validated PSI and author

6/30/2015. Lunch and Learn. Objectives. Who owns Quality and Patient Safety? We all do It s a Balance of Responsibility

The influence of societal individualism on a century of tobacco use: modelling the prevalence of smoking Appendices A and B

SCORES FOR 4 TH QUARTER, RD QUARTER, 2014

Type 1 Diabetes Australian Research Impact Analysis

Reliability and Validity of PPCs in the MHAC Program

Mandatory Elements of Healthcare Reform Walter Coleman. healthcare consulting

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Case study examining the impact of German reunification on life expectancy

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

Improving Quality of Care for Medicare Patients: Accountable Care Organizations

What ASMBS Members Need to Know About: New Medicare Payment Policy Governing Bariatric Surgery and Hospital Acquired Conditions (HACs)

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

CARDIOVASCULAR DISEASE AND DIABETES:

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

All about interrai. Len Gray Coordinator, interrai Network of Excellence in Acute Care April

Cover Page. The handle holds various files of this Leiden University dissertation.

MENTAL HEALTH INDICATORS: WITHIN 30-DAY HOSPITAL RE-ADMISSION

The OECD Health Care Quality Indicators Project

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

LEBANON. WCPT COUNTRY PROFILE December 2018

WCPT COUNTRY PROFILE December 2017 SERBIA

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

Incidental Durotomy/ Dural Tear.

DENMARK. WCPT COUNTRY PROFILE December 2018

Reporting Period and Reliability of AHRQ, CMS 30-day and HAC Quality Measures - Revised

Connecticut Joint Replacement Institute (CJRI) Outcomes Report

Surveillance report Published: 9 January 2017 nice.org.uk

GERMANY. WCPT COUNTRY PROFILE December 2018

Summary of Results for Laypersons

Venous Thromboembolism. Prevention

Data Comparability in Patient Safety Indicators

Medicare Hospital Acquired Conditions Reduction Program Andrew B. Wheeler Vice President of Federal Finance

Progress report on the analysis of cancer care

The Influence of Equating Methodology on Reported Trends in PISA

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).

Health Care Providers:

Progress Report: Health Care Quality Indicators Project. Meeting of OECD Health Data National Correspondents, 8 October, 2009, Paris

Overview of European Consumption Databases

AC T I O N - O R I E N T E D H O P E - C E N T E R E D C A R E E R D E V E L O P M E N T

Recommendations for Hospital Quality Measures in 2011:

Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Allied Health: Sustainable Integrated Health Care for all Australians

OECD Family database OECD - Social Policy Division - Directorate of Employment, Labour and Social Affairs

3.1 PHASE 2 OF THE GLOBAL PROJECT

The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS.

Monitoring polypharmacy and reducing problematic prescribing

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

Singapore s Progress on GLP and MAD

2016 Hospital Measures

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Kenneth W. Mahaffey, MD and Keith AA Fox, MB ChB

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN

2017 ICF GLOBAL CONSUMER AWARENESS STUDY

Emily J. Hadgkiss, 1 George A. Jelinek, 1,2 Tracey J. Weiland, 1,3 Naresh G. Pereira, 4 Claudia H. Marck, 1 and Dania M.

Extract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

The health economic landscape of cancer in Europe

1. SCOPE of GUIDELINE:

FY X Time (48 hrs for cardiac surgery) SCIP-Inf-4 Cardiac Surgery Patients With Controlled 6 A.M. Postoperative Blood

Urgent Medical Device Correction

An Update on the Bowel Cancer Screening Programme. Natasha Djedovic, London Hub Director 17 th September 2018

Online Supplementary Data. Country Number of centers Number of patients randomized

EASY-Care program in Iran. Dr Reza Fadayevatan, MD, MPH, PhD Head of Ageing Department, The University of Social welfare and Rehabilitation Sciences

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

EPIDEMIOLOGY. Accurate, in-depth information for understanding and assessing targeted markets

Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care

ECOO European Diploma in Optometry and Optics ECOO European Diploma in Optics A Status Report

Epidemiology Self Harm

Reza Fadayevatan Vida Alizad Ali Asgari

Outcomes of Health Systems : Towards the development of indicators of amenable mortality

What is the extent of gender bias in bioinformatics?

Boehringer Ingelheim Page 6 of 178 Study report for non-interventional studies based on existing data BI Study Number

International Symposium on Quality Assurance for Analytical Methods in Isotope Hydrology

50198 Federal Register / Vol. 75, No. 157 / Monday, August 16, 2010 / Rules and Regulations

Carry this card with you at all times. Show this card to any medical professional treating you. Patient Implant Card. Option ELITE Vena Cava Filter.

STATS Relationships between variables: Correlation

25 September 2012 Early Years Pathfinder. misuse. Insert name of presentation on Master Slide. Presenter: Dr Sarah J Jones

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

Annotations to the provisional agenda

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

Clinical Safety & Effectiveness Session # 9

Tobacco control measures in the Dutch National Prevention Agreement and expected tobacco industry responses

Transcription:

Analysis of the impact of AHRQ exclusions on the variation in Patient Safety Indicator (PSI) values by Vladimir Stevanovic Patient Safety Subgroup meeting Paris, 26 May 2011

Background HCQI Expert Group meeting in June 2009 Concerns were raised that PSI data may reflect rather coding and registration practices than actual differences in patient safety Several countries expressed reservations about the publication of PSIs in Health at a Glance 2009 due to perceived risk of misinterpretation The Secretariat proposed to undertake further analysis with the aim of validating the methodological approach

Background PSI Subgroup meeting in October 2009 The Secretariat presented a preliminary analysis on the impact of AHRQ exclusions by using NZ data The findings implied that the exclusions have varying impact on the country results and may distort indicator values apart from the obstetric ones The Secretariat proposed further analysis to be undertaken through a voluntary subsample of countries by replicating the same methods and using UPIs

Background HCQI Expert Group meeting in June 2010 Ten countries participated in the replication analysis: CAN, DNK, FIN, ISR, NOR, SNG, SPA, SWE, SWI, USA The results confirmed the previous findings that differences in coding practice, admission type definition and long LOS exclusion are likely to be the most important driving factor behind variations The decision was made to collect additional data by the means of regular HCQI 2010/11 data collection in order to better understand the impact of exclusions

Objectives To improve international comparability of PSIs by: Assessing the impact of admission type (ADMT) and and length of stay (LOS) exclusions on the rates for - PSI 07 Catheter-related bloodstream infection, - PSI 12 Pulmonary embolism or deep vein thrombosis, - PSI 13 Postoperative sepsis Exploring whether these exclusions account for any undesired or increased variation across countries The scope does NOT include exclusions that are inherent to the concept of an indicator by their nature

Methods All hospital discharges of one year Age =15 y or >15 y? yes PDx is immunocompromised state (list C-1 / W-1), or cancer (list C-2/W-2)? no SDx is immunocompromised state (list C-1 / W-1), or cancer (list C-2/W-2)? no PDx is identical to the numerator definition? Catheter-Related Bloodstream Infection Perform pre-exclusion calculations, see seperate flowchart Case is assigned to MDC 14 no no Exclude or the PDx is listed in table M3? yes yes Exclude Catheter-related bloodstram infections pre-exclusions Count and report number of All hospital discharges of one year, cases / admissions, ALOS, and yes Exclude age =15 years or > 15 years and mean number of secondary LOS < 24 hours or one day diagnoses (1) Count and report number of PDx is patients (countries with UPI identical to the yes only) / discharges (2) numerator definition? yes Exclude no Pre-exclusion and Post-exclusion stats (all discharges in a year AND age>=15 years AND LOS >= 24h) - the total number of discharges - the average length of stay - the average number of SDX no End Catheter-related bloodstram infections impact of length of stay (LOS) exclusions Count and report denominator cases (3) SDx is identical to the numerator definition? yes Count and report numerator cases (3) LOS > or = 48 hours or 2 days? yes no LOS is < 48 hours or < 2 days? yes LOS is < 24 hours or < 1 day? Add case to denominator population Calculate mean number of secondary diagnoses and ALOS of denominator population and report (6) Count and report denominator cases (7) yes Count denominator cases and report (4) SDx is identical to the numerator definition? yes yes Count denominator cases and report (5) SDx is identical to the numerator definition? yes Length of stay and Admission type exclusions Count numerator cases and report (4) Count numerator cases and report (5) SDx is identical to the numerator definition? yes Add case to numerator population - the numerator data - the denominator data Count numerator cases and report (8)

Additional data

Countries Australia Belgium Canada Denmark Finland France Iceland Israel Italy New Zealand Singapore Spain Sweden Switzerland United States

Results PSI 07 Catheter-related bloodstream infection (LOS excl)

Results PSI 07 Catheter-related bloodstream infection (LOS excl) Spearman-rank test (no LOS excl vs <1 day, <2 days) = 0.89, 0.84 (both p<0.01)

Results PSI 12 Postoperative PE or DVT (LOS excl)

Results PSI 12 Postoperative PE or DTV (LOS excl) Spearman-rank test (no LOS excl vs <1 day, <2 days) = 0.78,(p<0.01), 0.59 (p=0.07)

Results PSI 13 Postoperative sepsis (LOS excl)

Results PSI 12 Postoperative sepsis (LOS excl) Spearman-rank test (no LOS excl vs <1-3 days, <4 days) = 0.93-97, 0.78

Results PSI 12 Postoperative sepsis (LOS excl)

Results PSI 13 Postoperative sepsis (LOS & ADMT excl)

Results PSI 12 Postoperative sepsis (LOS & ADMT excl) Spearman-rank test (no ADMT vs with ADMT) = -0.19 (p=0.60)

Results PSI 12 Postoperative sepsis (ADMT distribution)

Results PSI 12 Postoperative sepsis (modified excl criteria)

Results PSI 12 Postoperative sepsis (modified excl criteria)

Publication PSI 07 Catheter-related bloodstream infection Min/Max ratio = 100 fold Variation in coding practices? Inflammatory conditions?

Recommendations 1. The exclusion criteria for PSI 07 Catheter-related bloodstream infections and PSI 12 Postoperative pulmonary embolism and deep vein thrombosis are appropriate, hence there is no need to change the existing LOS<2 days exclusion. 2. For PSI 13 Postoperative sepsis, exclusions of discharges with LOS<4 days and non-elective (acute) type admissions account for an increased variation between countries and cause bias in the resulting postoperative sepsis rates. It is recommended to drop the admission type exclusion criterion from the algorithm and to use the modified LOS<3 days exclusion instead.

Recommendations - cont. 3. For PSI 07 Catheter-related bloodstream infection, remaining ambiguities in the definition make this indicator not fit for reporting at this moment. 4. The following indicators seem to be robust enough and are therefore recommended for publication in Health at a Glance 2011: - PSI 05 Foreign body left in during procedure - PSI 12 Post-operative pulm. embolism or deep vein thrombosis - PSI 13 Post-operative sepsis - PSI 15 Accidental puncture or laceration - PSI 18 Obstetric trauma - vaginal delivery with instrument - PSI 19 Obstetric trauma - vaginal delivery without instrument

Optimal system requirements Unique patient identifier (UPI) Near miss and adverse events register Present on admission (POA) flag Standardised registration/coding practice Mapping between classification systems Calculation method/algorithm adjusted for international comparison - exclusions inherent to the concept of PSI - adjustments for the effect of confounders

Members of the Patient Safety Subgroup are invited to Comment on findings from the analysis, Decide on whether to change the algorithm used for the calculation of PSI13 Postoperative sepsis as recommended by this report, Decide on whether to adjust patient safety indicator rates by the mean number of secondary diagnoses among patients at risk as (previously presented by Saskia Drösler and Patrick Romano and discussed in 2009/10), Make recommendations for the continuation of the development work on PSIs (agenda item 4). Make recommendations on which patient safety indicators should be published in the chapter on Quality of Care in Health at a Glance 2011 (agenda item 5).